These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 1758897

  • 1. Effect of low-molecular casein and gelatin on absorption of ibuprofen after oral and rectal administration.
    Kimura S, Imai T, Otagiri M.
    Pharm Acta Helv; 1991; 66(4):120-4. PubMed ID: 1758897
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of low-molecular gelatin as a pharmaceutical additive for rapidly absorbed oral dosage formulation.
    Kimura S, Imai T, Otagiri M.
    Chem Pharm Bull (Tokyo); 1991 May; 39(5):1328-9. PubMed ID: 1914011
    [Abstract] [Full Text] [Related]

  • 3. Improved dissolution and absorption of drugs using low molecular gelatin.
    Kimura S, Nishiyama T, Imai T, Otagiri M.
    Acta Pharm Nord; 1990 May; 2(2):65-72. PubMed ID: 2354031
    [Abstract] [Full Text] [Related]

  • 4. Casein hydrolysate as a rapid and/or enteric dissolving additive for oral drugs.
    Imai T, Nishiyama T, Shameem M, Otagiri M.
    Pharm Dev Technol; 1998 May; 3(2):225-32. PubMed ID: 9653760
    [Abstract] [Full Text] [Related]

  • 5. Pharmaceutical evaluation of ibuprofen fast-absorbed syrup containing low-molecular-weight gelatin.
    Kimura S, Imai T, Ueno M, Otagiri M.
    J Pharm Sci; 1992 Feb; 81(2):141-4. PubMed ID: 1545352
    [Abstract] [Full Text] [Related]

  • 6. Bioavailability of ibuprofen from oral and suppository preparations in rats.
    Kaka JS, Tekle A.
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):171-82. PubMed ID: 1604043
    [Abstract] [Full Text] [Related]

  • 7. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds.
    Iwanaga K, Sumizawa T, Miyazaki M, Kakemi M.
    Int J Pharm; 2010 Mar 30; 388(1-2):123-8. PubMed ID: 20045041
    [Abstract] [Full Text] [Related]

  • 8. Rapidly absorbed solid oral formulations of ibuprofen using water-soluble gelatin.
    Imai T, Kimura S, Iijima T, Miyoshi T, Ueno M, Otagiri M.
    J Pharm Pharmacol; 1990 Sep 30; 42(9):615-9. PubMed ID: 1981899
    [Abstract] [Full Text] [Related]

  • 9. Effects of absorption rate on the pre-systemic chiral inversion of ibuprofen in rabbits.
    Doki K, Hayakawa T, Lin W, Yanaguimoto H, Ding G, Inotsume N.
    J Pharm Pharmacol; 2003 Aug 30; 55(8):1091-7. PubMed ID: 12956898
    [Abstract] [Full Text] [Related]

  • 10. Perioperative pharmacokinetics of ibuprofen enantiomers after rectal administration.
    Kyllönen M, Olkkola KT, Seppälä T, Ryhänen P.
    Paediatr Anaesth; 2005 Jul 30; 15(7):566-73. PubMed ID: 15960640
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence of absorption rate dependency of ibuprofen inversion in the rat.
    Sattari S, Jamali F.
    Chirality; 1994 Jul 30; 6(5):435-9. PubMed ID: 8068501
    [Abstract] [Full Text] [Related]

  • 13. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G, Monti N, Brogin G, Gallina M, Eandi M, Persiani S, Bani M, Della Pepa C, Zara G, Strolin Benedetti M.
    Chirality; 1997 Jul 30; 9(3):297-302. PubMed ID: 9176996
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of ibuprofen enantiomers in dogs.
    Beck WS, Geisslinger G, Engler H, Brune K.
    Chirality; 1991 Jul 30; 3(3):165-9. PubMed ID: 1911048
    [Abstract] [Full Text] [Related]

  • 15. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
    Lamprecht A, Saumet JL, Roux J, Benoit JP.
    Int J Pharm; 2004 Jul 08; 278(2):407-14. PubMed ID: 15196644
    [Abstract] [Full Text] [Related]

  • 16. Rectal absorption of [Bis (acetato) ammine dichloro (cyclohexylamine) platinum(IV)] (BMS-182751), a new anti-tumor agent, in rats.
    Tanaka M, Kuwahara E, Shimizu T, Chikazawa H, Hisada S, Takahashi N.
    Biol Pharm Bull; 1999 May 08; 22(5):521-6. PubMed ID: 10375175
    [Abstract] [Full Text] [Related]

  • 17. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
    Newa M, Bhandari KH, Oh DH, Kim YR, Sung JH, Kim JO, Woo JS, Choi HG, Yong CS.
    Arch Pharm Res; 2008 Nov 08; 31(11):1497-507. PubMed ID: 19023548
    [Abstract] [Full Text] [Related]

  • 18. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
    Fetih G, Lindberg S, Itoh K, Okada N, Fujita T, Habib F, Artersson P, Attia M, Yamamoto A.
    Int J Pharm; 2005 Apr 11; 293(1-2):127-35. PubMed ID: 15778050
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R, Nolting A, Roy P, Fiske W, Benedek I, Abramowitz W.
    Clin Ther; 2004 Dec 11; 26(12):2015-25. PubMed ID: 15823765
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of ibuprofen after intravenous and oral administration and assessment of safety of administration to healthy foals.
    Breuhaus BA, DeGraves FJ, Honore EK, Papich MG.
    Am J Vet Res; 1999 Sep 11; 60(9):1066-73. PubMed ID: 10490073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.